• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于磁共振成像的纹理分析在骨肉瘤化疗反应评估中的应用。

Texture analysis for chemotherapy response evaluation in osteosarcoma using MR imaging.

机构信息

Centre for Biomedical Engineering, Indian Institute of Technology Delhi, New Delhi, India.

Department of Radio Diagnosis, All India Institute of Medical Sciences, New Delhi, India.

出版信息

NMR Biomed. 2021 Feb;34(2):e4426. doi: 10.1002/nbm.4426. Epub 2020 Oct 20.

DOI:10.1002/nbm.4426
PMID:33078438
Abstract

The efficacy of MRI-based statistical texture analysis (TA) in predicting chemotherapy response among patients with osteosarcoma was assessed. Forty patients (male: female = 31:9; age = 17.2 ± 5.7 years) with biopsy-proven osteosarcoma were analyzed in this prospective study. Patients were scheduled for three cycles of neoadjuvant chemotherapy (NACT) and diffusion-weighted MRI acquisition at three time points: at baseline (t0), after the first NACT (t1) and after the third NACT (t2) using a 1.5 T scanner. Eight patients (nonsurvivors) died during NACT while 34 patients (survivors) completed the NACT regimen followed by surgery. Histopathological evaluation was performed in the resected tumor to assess NACT response (responder [≤50% viable tumor] and nonresponder [>50% viable tumor]) and revealed nonresponder: responder = 20:12. Apparent diffusion coefficient (ADC) and intravoxel incoherent motion (IVIM) parameters, diffusion coefficient (D), perfusion coefficient (D*) and perfusion fraction (f) were evaluated. A total of 25 textural features were evaluated on ADC, D, D* and f parametric maps and structural T1-weighted (T1W) and T2-weighted (T2W) images in the entire tumor volume using 3D TA methods gray-level cooccurrence matrix (GLCM), neighborhood gray-tone-difference matrix (NGTDM) and run-length matrix (RLM). Receiver-operating-characteristic curve analysis was performed on the selected textural feature set to assess the role of TA features (a) as marker(s) of tumor aggressiveness leading to mortality at baseline and (b) in predicting the NACT response among survivors in the course of treatment. Findings showed that the NGTDM features coarseness, busyness and strength quantifying tumor heterogeneity in D, D* and f maps and T1W and T2W images were useful markers of tumor aggressiveness in identifying the nonsurvivor group (area-under-the-curve [AUC] = 0.82-0.88) at baseline. The GLCM features contrast and correlation, NGTDM features contrast and complexity and RLM feature short-run-low-gray-level-emphasis quantifying homogeneity/terogeneity in tumor were effective markers for predicting chemotherapeutic response using D (AUC = 0.80), D* (AUC = 0.80) and T2W (AUC = 0.70) at t0, and D* (AUC = 0.80) and f (AUC = 0.70) at t1. 3D statistical TA features might be useful as imaging-based markers for characterizing tumor aggressiveness and predicting chemotherapeutic response in patients with osteosarcoma.

摘要

本研究旨在评估基于 MRI 的统计纹理分析(TA)在预测骨肉瘤患者化疗反应中的疗效。本前瞻性研究纳入了 40 名经活检证实的骨肉瘤患者(男:女=31:9;年龄=17.2±5.7 岁)。患者接受了三个周期的新辅助化疗(NACT),并在三个时间点进行扩散加权 MRI 采集:基线(t0)、第一次 NACT 后(t1)和第三次 NACT 后(t2),使用 1.5T 扫描仪。8 名患者(死亡组)在 NACT 期间死亡,34 名患者(存活组)完成了 NACT 方案,随后进行了手术。对切除的肿瘤进行组织病理学评估,以评估 NACT 反应(应答者[≤50%存活肿瘤]和非应答者[>50%存活肿瘤]),结果显示非应答者:应答者=20:12。评估了表观扩散系数(ADC)和体素内不相干运动(IVIM)参数、扩散系数(D)、灌注系数(D*)和灌注分数(f)。使用 3D TA 方法灰度共生矩阵(GLCM)、邻域灰度差矩阵(NGTDM)和游程长度矩阵(RLM),在整个肿瘤体积的 ADC、D、D和 f 参数图以及结构 T1 加权(T1W)和 T2 加权(T2W)图像上评估了总共 25 个纹理特征。对选定的纹理特征集进行受试者工作特征曲线分析,以评估 TA 特征(a)作为导致基线时死亡的肿瘤侵袭性标志物的作用,以及(b)在治疗过程中预测幸存者 NACT 反应的作用。结果表明,D、D、f 图和 T1W、T2W 图像中 NGTDM 特征粗糙度、繁忙度和强度定量评估肿瘤异质性,是基线时识别非存活组的有用标志物(曲线下面积[AUC]=0.82-0.88)。GLCM 特征对比度和相关性、NGTDM 特征对比度和复杂性以及 RLM 特征短运行低灰度强调定量评估肿瘤的均匀性/异质性,是使用 D(AUC=0.80)、D*(AUC=0.80)和 T2W(AUC=0.70)在 t0 时预测化疗反应以及 D*(AUC=0.80)和 f(AUC=0.70)在 t1 时预测化疗反应的有效标志物。3D 统计 TA 特征可能是一种有用的影像学标志物,可用于表征骨肉瘤患者的肿瘤侵袭性和预测化疗反应。

相似文献

1
Texture analysis for chemotherapy response evaluation in osteosarcoma using MR imaging.基于磁共振成像的纹理分析在骨肉瘤化疗反应评估中的应用。
NMR Biomed. 2021 Feb;34(2):e4426. doi: 10.1002/nbm.4426. Epub 2020 Oct 20.
2
Intravoxel incoherent motion (IVIM) for response assessment in patients with osteosarcoma undergoing neoadjuvant chemotherapy.体素内不相干运动(IVIM)在接受新辅助化疗的骨肉瘤患者反应评估中的应用。
Eur J Radiol. 2019 Oct;119:108635. doi: 10.1016/j.ejrad.2019.08.004. Epub 2019 Aug 10.
3
Non-invasive intravoxel incoherent motion MRI in prediction of histopathological response to neoadjuvant chemotherapy and survival outcome in osteosarcoma at the time of diagnosis.基于体素内不相干运动磁共振成像的无创性预测骨肉瘤患者新辅助化疗的组织病理学反应及诊断时的生存结局。
J Transl Med. 2022 Dec 27;20(1):625. doi: 10.1186/s12967-022-03838-1.
4
Intravoxel incoherent motion and dynamic contrast-enhanced magnetic resonance imaging for neoadjuvant chemotherapy response evaluation in patients with osteosarcoma.体素内不相干运动及动态对比增强磁共振成像用于骨肉瘤患者新辅助化疗反应评估
Eur J Radiol. 2023 May;162:110790. doi: 10.1016/j.ejrad.2023.110790. Epub 2023 Mar 21.
5
T1 mapping as a surrogate marker of chemotherapy response evaluation in patients with osteosarcoma.T1 映射作为骨肉瘤患者化疗反应评估的替代标志物。
Eur J Radiol. 2022 Mar;148:110170. doi: 10.1016/j.ejrad.2022.110170. Epub 2022 Jan 20.
6
Feasibility of multi-parametric magnetic resonance imaging combined with machine learning in the assessment of necrosis of osteosarcoma after neoadjuvant chemotherapy: a preliminary study.多参数磁共振成像结合机器学习在新辅助化疗后骨肉瘤坏死评估中的可行性:一项初步研究。
BMC Cancer. 2020 Apr 15;20(1):322. doi: 10.1186/s12885-020-06825-1.
7
Evaluation of Monoexponential, Stretched-Exponential and Intravoxel Incoherent Motion MRI Diffusion Models in Early Response Monitoring to Neoadjuvant Chemotherapy in Patients With Breast Cancer-A Preliminary Study.单指数、拉伸指数和体素内不相干运动 MRI 扩散模型在乳腺癌新辅助化疗早期疗效监测中的评估——一项初步研究。
J Magn Reson Imaging. 2022 Oct;56(4):1079-1088. doi: 10.1002/jmri.28113. Epub 2022 Feb 14.
8
Assessing the Early Response of Advanced Cervical Cancer to Neoadjuvant Chemotherapy Using Intravoxel Incoherent Motion Diffusion-weighted Magnetic Resonance Imaging: A Pilot Study.使用体素内不相干运动扩散加权磁共振成像评估晚期宫颈癌对新辅助化疗的早期反应:一项初步研究。
Chin Med J (Engl). 2016 Mar 20;129(6):665-71. doi: 10.4103/0366-6999.177995.
9
Quantitative intravoxel incoherent motion parameters derived from whole-tumor volume for assessing pathological complete response to neoadjuvant chemotherapy in locally advanced rectal cancer.基于全肿瘤容积的体素内不相干运动定量参数评估局部进展期直肠癌新辅助化疗的病理完全缓解。
J Magn Reson Imaging. 2018 Jul;48(1):248-258. doi: 10.1002/jmri.25931. Epub 2017 Dec 27.
10
Multiparametric MRI with diffusion-weighted imaging in predicting response to chemotherapy in cases of osteosarcoma and Ewing's sarcoma.磁共振多参数成像弥散加权成像预测骨肉瘤和尤文肉瘤化疗反应的价值。
Br J Radiol. 2020 Nov 1;93(1115):20200257. doi: 10.1259/bjr.20200257. Epub 2020 Oct 15.

引用本文的文献

1
A machine learning model utilizing CT radiomics features and peripheral blood inflammatory markers predicts the prognosis of patients with unresectable esophageal squamous cell carcinoma undergoing PD-1 inhibitor combined with concurrent chemoradiotherapy.一种利用CT影像组学特征和外周血炎症标志物的机器学习模型可预测接受PD-1抑制剂联合同步放化疗的不可切除食管鳞状细胞癌患者的预后。
J Cancer. 2025 Mar 3;16(6):2001-2014. doi: 10.7150/jca.105171. eCollection 2025.
2
Retrospective BReast Intravoxel Incoherent Motion Multisite (BRIMM) multisoftware study.回顾性乳腺体素内不相干运动多中心(BRIMM)多软件研究。
Front Oncol. 2025 Feb 24;15:1524634. doi: 10.3389/fonc.2025.1524634. eCollection 2025.
3
Integrating deep learning and machine learning for improved CKD-related cortical bone assessment in HRpQCT images: A pilot study.
整合深度学习与机器学习以改善高分辨率外周定量CT图像中与慢性肾脏病相关的皮质骨评估:一项初步研究。
Bone Rep. 2024 Dec 26;24:101821. doi: 10.1016/j.bonr.2024.101821. eCollection 2025 Mar.
4
Reproducibility of spatial penalty-based methodologies for intravoxel incoherent motion analysis with diffusion MRI.基于体素内不相干运动分析的扩散 MRI 空间惩罚方法的可重复性。
Sci Rep. 2024 Oct 1;14(1):22811. doi: 10.1038/s41598-024-71173-0.
5
Application of predictive model based on CT radiomics and machine learning in diagnosis for occult locally advanced esophageal squamous cell carcinoma before treatment: A two-center study.基于CT影像组学和机器学习的预测模型在隐匿性局部晚期食管鳞状细胞癌治疗前诊断中的应用:一项双中心研究。
Transl Oncol. 2024 Sep;47:102050. doi: 10.1016/j.tranon.2024.102050. Epub 2024 Jul 8.
6
Evaluation of the neoadjuvant chemotherapy response in osteosarcoma using the MRI DWI-based machine learning radiomics nomogram.使用基于MRI扩散加权成像的机器学习影像组学列线图评估骨肉瘤新辅助化疗反应
Front Oncol. 2024 Mar 21;14:1345576. doi: 10.3389/fonc.2024.1345576. eCollection 2024.
7
Prediction of non-perfusion volume ratio for uterine fibroids treated with ultrasound-guided high-intensity focused ultrasound based on MRI radiomics combined with clinical parameters.基于 MRI 放射组学与临床参数联合预测超声引导高强度聚焦超声治疗子宫肌瘤的非灌注体积比。
Biomed Eng Online. 2023 Dec 13;22(1):123. doi: 10.1186/s12938-023-01182-z.
8
Radiomics in Hypopharyngeal Cancer Management: A State-of-the-Art Review.下咽癌管理中的影像组学:最新综述
Biomedicines. 2023 Mar 6;11(3):805. doi: 10.3390/biomedicines11030805.
9
Predictive value of DCE-MRI and IVIM-DWI in osteosarcoma patients with neoadjuvant chemotherapy.动态对比增强磁共振成像(DCE-MRI)和体素内不相干运动扩散加权成像(IVIM-DWI)在骨肉瘤新辅助化疗患者中的预测价值
Front Oncol. 2022 Oct 14;12:967450. doi: 10.3389/fonc.2022.967450. eCollection 2022.
10
An updated systematic review of radiomics in osteosarcoma: utilizing CLAIM to adapt the increasing trend of deep learning application in radiomics.骨肉瘤中放射组学的最新系统评价:利用CLAIM适应放射组学中深度学习应用的增长趋势。
Insights Imaging. 2022 Aug 20;13(1):138. doi: 10.1186/s13244-022-01277-6.